Ascension reported a 399.4% year-over-year increase in outpatient surgery visits during the first quarter of fiscal 2027, largely reflecting its acquisition of AMSURG, which contributed approximately 283,000 surgical visits. Excluding the acquisition, outpatient surgery volume still increased 3.6% compared with the same quarter in fiscal 2026, indicating underlying growth in ambulatory procedures.
Ascension completed its $3.9 billion AMSURG acquisition in June 2026, adding approximately 250 ambulatory surgery centers (ASCs) to its existing network of around 50. The transaction followed an agreement to divest seven centers to address Federal Trade Commission antitrust concerns. AMSURG has also continued expanding its portfolio through additional acquisitions, including two GI centers in California. Ascension says its strategy involves shifting selected procedures to outpatient settings, expanding ASC partnerships and investing in complementary services.
The volume growth contrasts with weaker elective surgery demand reported by some other large health systems, including HCA Healthcare and Community Health Systems. Despite the increase in surgical activity, Ascension reported an operating loss of $84.4 million for the quarter, compared with $87.9 million a year earlier. Revenue rose 5.1% to $6.4 billion.

